<DOC>
	<DOCNO>NCT00726180</DOCNO>
	<brief_summary>The majority pf breast cancer present ER-positive , many able target multiple hormonal therapy . Altering ER-negative tumor increase ER expression potential benefit patient make hormonal therapy therapeutic option possibly improve overall prognosis .</brief_summary>
	<brief_title>Use Trastuzumab Induce Increased ER Expression ER-negative/Low , Her-2/Neu Positive Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Trastuzumab</mesh_term>
	<criteria>Women Her2 positive ER negative ERlow breast cancer metastasize , spread part body , eligible study . Participants must either core biopsy incisional biopsy breast cancer , yet definitive breast surgery , include lumpectomy mastectomy . Participants may BRCA mutation find genetic testing . Participants yet receive treatment breast cancer , include : chemotherapy , hormonal therapy , trastuzumab .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Breast cancer</keyword>
	<keyword>Women</keyword>
	<keyword>w/Her2</keyword>
	<keyword>positive</keyword>
	<keyword>ERnegative</keyword>
	<keyword>metastasize</keyword>
</DOC>